, Tracking Stock Market Picks
Enter Symbol:
Seattle Genetics, Inc. (SGEN) [hlAlert]

down 64.25 %

Seattle Genetics, Inc. (SGEN) rated Sell by BioLogic Equity Research

Posted on: Wednesday,  Mar 9, 2011  12:25 PM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell Seattle Genetics, Inc. (NASDAQ: SGEN) on 03/09/2011, when the stock price was $14.74.
Since then, Seattle Genetics, Inc. has gained 179.78% as of 01/14/2016's recent price of $41.24.
If you would have followed this BioLogic Equity Research's recommendation on SGEN, you would have lost 64.25% of your investment in 1772 days.

Seatlle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Using its monoclonal antibody-based technologies and its expertise in cancer, the company have assembled a portfolio of drug candidates targeted to many types of human cancers. The company utilizes its monoclonal antibody-based technologies to increase the potency and efficacy of antibodies with specificity for cancer. The company is testing our two most advanced product candidates, SGN-15 and SGN-10, in patients with breast, colon, prostate or other cancers.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/9/2011 12:25 PM Sell
as of 12/30/2011
1 Week down  -0.78 %
1 Month down  -0.54 %
3 Months up  12.18 %
1 YTD down  -13.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy